Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system

This study looked at how often chemotherapy is used and how well it works for people with stage II/III colorectal cancer. We used electronic health records from a large managed care organization to study 3 different groups of patients. We found that although chemotherapy can help people live longer,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of managed care & specialty pharmacy 2023-06, Vol.29 (6), p.635-646
Main Authors: Chen, Yilin, Shankaran, Veena, Hahn, Erin E, Haupt, Eric C, Bansal, Aasthaa
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study looked at how often chemotherapy is used and how well it works for people with stage II/III colorectal cancer. We used electronic health records from a large managed care organization to study 3 different groups of patients. We found that although chemotherapy can help people live longer, many people who could benefit from it do not receive it. This was especially true for people with high-risk stage II colon and stage III colorectal cancer.
ISSN:2376-0540
2376-1032
DOI:10.18553/jmcp.2023.29.6.635